Mary Hesdorffer received her undergraduate degree at the College of New Rochelle in New York and went on to receive her Masters of Science at the same institution. She is a Nurse Practitioner and spent nearly 20 years actively treating patients with mesothelioma. Ms. Hesdorffer has an expertise in the development and implementation of clinical trials. Her work has been published in peer-reviewed scientific journals and she has lectured both nationally and internationally on the topics pertaining to mesothelioma with particular emphasis on clinical trials as well as symptom and disease management.Ms. Hesdorffer has been a strong voice in urging increased transparency to the medical and legal issues surrounding mesothelioma with a strong emphasis on ethics. She is passionate in her commitment to the treatment and management of this disease and hopes to increase awareness of the need to advance the science that will lead to a cure. Mary is the Executive Director of the Mesothelioma Applied Research Foundation. Gleneara E. Bates-Pappas, LMSW, is currently a doctoral candidate at CUNY Graduate Center, an adjunct lecturer at Columbia University School of Social Work, Silberman School of Social Work at Hunter College, New York University Silver School of Social Work and a psychological counselor at CUNY School of Labor and Urban Studies. She received her bachelors degree from the University of Arizona in political science and economics minoring in Africana studies and went on to receive her master, basic science and legal training from Columbia University. Her doctoral research explores the environmental risk factors for lung cancer mortality among racially ethnic minorities living in New York. Her current research projects aim to elucidate the bio-physiological aspects of tumor resistance in response to chemotherapy and the use of telemedicine to improve quality-of-life and cognitive function in post-treatment cancer survivors. In addition to exploring ways to use virtual and augmented reality to reduce anxiety during treatment in Pediatric oncology patients.As a cancer researcher, she managed a translational research laboratory at Columbia University Medical Center where she conceptualized and conducted research on heat shock proteins and their role in tumor resistance in response to chemotherapy and the role of platinum agents in inducing checkpoint inhibitors related to tumor progression on the quality of life of patients and their primary caregivers during and post-treatment. In addition, she serves on the American Society of Clinical Oncology Cancer Survivorship Committee and The International Association for the Study of Lung Cancer Smoking Cessation Committee

• Chapter 1: The history of Mesothelioma and medical research.- Part I: Mesothelioma treatment_Chapter 2: Early history of Peritoneal surgery.- Chapter 3: History of Pleural surgical treatment.- Chapter 4: History of clinical trials.- Chapter 5: Caring for patients undergoing pleural surgery.- Chapter 6: Peritoneal Treatment.- Chapter 7: Radiation Therapy.- Part II: Therapeutic treatments: chemotherapy, Biotherapy, and immunotherapy_Chapter 8: Standard Chemotherapy.- Chapter 9: Caring for patients during and after Immunotherapy treatment.- Chapter 10: Biotherapy treatment.- Part III: Supportive Health Care for treatment_Chapter 11: Pulmonary rehab.- Chapter 12: Physical therapy.- Chapter 13: Occupation therapy.- Chapter 14: Nutrition.- Chapter 15: Mental health treatment.- Chapter 16: Pain Management.- Chapter 17: Palliative Care.- Chapter 18: Long Term care and Survivorship.- Chapter 19: End- of-Life care.- Chapter 20: Patient perspective on mesothelioma treatment.- Part IV: Public health impact of asbestos world wide_Chapter 21: Public health impact of asbestos world wide: History of asbestos use.- Chapter 22: Public health impact of asbestos world wide: What is the current public health impact?.- Chapter 23: Nurse Educator Asbestos Related Diseases the Lung Foundation Australia.- Part V: The future of Mesothelioma Research_Chapter 24: Clinical Trials.- Chapter 25: Basic Science Research.- Chapter 26: Genetics and Genetic Counseling.- Part VI: Patient's perspective_Chapter 27: Patient involment in research.- Chapter 28: The development of mesothelioma foundations and patient support.- Chapter 29: The impact of social media mesothelioma.

Mary Hesdorffer received her undergraduate degree at the College of New Rochelle in New York and went on to receive her Masters of Science at the same institution. She is a Nurse Practitioner and spent nearly 20 years actively treating patients with mesothelioma. Ms. Hesdorffer has an expertise in the development and implementation of clinical trials. Her work has been published in peer-reviewed scientific journals and she has lectured both nationally and internationally on the topics pertaining to mesothelioma with particular emphasis on clinical trials as well as symptom and disease management.Ms. Hesdorffer has been a strong voice in urging increased transparency to the medical and legal issues surrounding mesothelioma with a strong emphasis on ethics. She is passionate in her commitment to the treatment and management of this disease and hopes to increase awareness of the need to advance the science that will lead to a cure. Mary is the Executive Director of the Mesothelioma Applied Research Foundation. Gleneara E. Bates-Pappas, LMSW, is currently a doctoral candidate at CUNY Graduate Center, an adjunct lecturer at Columbia University School of Social Work, Silberman School of Social Work at Hunter College, New York University Silver School of Social Work and a psychological counselor at CUNY School of Labor and Urban Studies. She received her bachelors degree from the University of Arizona in political science and economics minoring in Africana studies and went on to receive her master, basic science and legal training from Columbia University. Her doctoral research explores the environmental risk factors for lung cancer mortality among racially ethnic minorities living in New York. Her current research projects aim to elucidate the bio-physiological aspects of tumor resistance in response to chemotherapy and the use of telemedicine to improve quality-of-life and cognitive function in post-treatment cancer survivors. In addition to exploring ways to use virtual and augmented reality to reduce anxiety during treatment in Pediatric oncology patients.As a cancer researcher, she managed a translational research laboratory at Columbia University Medical Center where she conceptualized and conducted research on heat shock proteins and their role in tumor resistance in response to chemotherapy and the role of platinum agents in inducing checkpoint inhibitors related to tumor progression on the quality of life of patients and their primary caregivers during and post-treatment. In addition, she serves on the American Society of Clinical Oncology Cancer Survivorship Committee and The International Association for the Study of Lung Cancer Smoking Cessation Committee

• Chapter 1: The history of Mesothelioma and medical research.- Part I: Mesothelioma treatment_Chapter 2: Early history of Peritoneal surgery.- Chapter 3: History of Pleural surgical treatment.- Chapter 4: History of clinical trials.- Chapter 5: Caring for patients undergoing pleural surgery.- Chapter 6: Peritoneal Treatment.- Chapter 7: Radiation Therapy.- Part II: Therapeutic treatments: chemotherapy, Biotherapy, and immunotherapy_Chapter 8: Standard Chemotherapy.- Chapter 9: Caring for patients during and after Immunotherapy treatment.- Chapter 10: Biotherapy treatment.- Part III: Supportive Health Care for treatment_Chapter 11: Pulmonary rehab.- Chapter 12: Physical therapy.- Chapter 13: Occupation therapy.- Chapter 14: Nutrition.- Chapter 15: Mental health treatment.- Chapter 16: Pain Management.- Chapter 17: Palliative Care.- Chapter 18: Long Term care and Survivorship.- Chapter 19: End- of-Life care.- Chapter 20: Patient perspective on mesothelioma treatment.- Part IV: Public health impact of asbestos world wide_Chapter 21: Public health impact of asbestos world wide: History of asbestos use.- Chapter 22: Public health impact of asbestos world wide: What is the current public health impact?.- Chapter 23: Nurse Educator Asbestos Related Diseases the Lung Foundation Australia.- Part V: The future of Mesothelioma Research_Chapter 24: Clinical Trials.- Chapter 25: Basic Science Research.- Chapter 26: Genetics and Genetic Counseling.- Part VI: Patient's perspective_Chapter 27: Patient involment in research.- Chapter 28: The development of mesothelioma foundations and patient support.- Chapter 29: The impact of social media mesothelioma.

Mary Hesdorffer received her undergraduate degree at the College of New Rochelle in New York and went on to receive her Masters of Science at the same institution. She is a Nurse Practitioner and spent nearly 20 years actively treating patients with mesothelioma. Ms. Hesdorffer has an expertise in the development and implementation of clinical trials. Her work has been published in peer-reviewed scientific journals and she has lectured both nationally and internationally on the topics pertaining to mesothelioma with particular emphasis on clinical trials as well as symptom and disease management.Ms. Hesdorffer has been a strong voice in urging increased transparency to the medical and legal issues surrounding mesothelioma with a strong emphasis on ethics. She is passionate in her commitment to the treatment and management of this disease and hopes to increase awareness of the need to advance the science that will lead to a cure. Mary is the Executive Director of the Mesothelioma Applied Research Foundation. Gleneara E. Bates-Pappas, LMSW, is currently a doctoral candidate at CUNY Graduate Center, an adjunct lecturer at Columbia University School of Social Work, Silberman School of Social Work at Hunter College, New York University Silver School of Social Work and a psychological counselor at CUNY School of Labor and Urban Studies. She received her bachelors degree from the University of Arizona in political science and economics minoring in Africana studies and went on to receive her master, basic science and legal training from Columbia University. Her doctoral research explores the environmental risk factors for lung cancer mortality among racially ethnic minorities living in New York. Her current research projects aim to elucidate the bio-physiological aspects of tumor resistance in response to chemotherapy and the use of telemedicine to improve quality-of-life and cognitive function in post-treatment cancer survivors. In addition to exploring ways to use virtual and augmented reality to reduce anxiety during treatment in Pediatric oncology patients.As a cancer researcher, she managed a translational research laboratory at Columbia University Medical Center where she conceptualized and conducted research on heat shock proteins and their role in tumor resistance in response to chemotherapy and the role of platinum agents in inducing checkpoint inhibitors related to tumor progression on the quality of life of patients and their primary caregivers during and post-treatment. In addition, she serves on the American Society of Clinical Oncology Cancer Survivorship Committee and The International Association for the Study of Lung Cancer Smoking Cessation Committee

• Chapter 1: The history of Mesothelioma and medical research.- Part I: Mesothelioma treatment_Chapter 2: Early history of Peritoneal surgery.- Chapter 3: History of Pleural surgical treatment.- Chapter 4: History of clinical trials.- Chapter 5: Caring for patients undergoing pleural surgery.- Chapter 6: Peritoneal Treatment.- Chapter 7: Radiation Therapy.- Part II: Therapeutic treatments: chemotherapy, Biotherapy, and immunotherapy_Chapter 8: Standard Chemotherapy.- Chapter 9: Caring for patients during and after Immunotherapy treatment.- Chapter 10: Biotherapy treatment.- Part III: Supportive Health Care for treatment_Chapter 11: Pulmonary rehab.- Chapter 12: Physical therapy.- Chapter 13: Occupation therapy.- Chapter 14: Nutrition.- Chapter 15: Mental health treatment.- Chapter 16: Pain Management.- Chapter 17: Palliative Care.- Chapter 18: Long Term care and Survivorship.- Chapter 19: End- of-Life care.- Chapter 20: Patient perspective on mesothelioma treatment.- Part IV: Public health impact of asbestos world wide_Chapter 21: Public health impact of asbestos world wide: History of asbestos use.- Chapter 22: Public health impact of asbestos world wide: What is the current public health impact?.- Chapter 23: Nurse Educator Asbestos Related Diseases the Lung Foundation Australia.- Part V: The future of Mesothelioma Research_Chapter 24: Clinical Trials.- Chapter 25: Basic Science Research.- Chapter 26: Genetics and Genetic Counseling.- Part VI: Patient's perspective_Chapter 27: Patient involment in research.- Chapter 28: The development of mesothelioma foundations and patient support.- Chapter 29: The impact of social media mesothelioma.